Answer
No, emtricitabine/tenofovir disoproxil is not recommended for children and adolescents with renal impairment, should not be started in those with renal impairment, and should be discontinued if renal impairment develops during therapy.
Sources for this answer
- Emtricitabine/Tenofovir disoproxil Dr. Reddy's 200 mg/245 mg Film-Coated TabletsDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 11Document updated
Sources checked